Lanean...
Recombinant human adenovirus-p53 improves the outcome of mid-late stage pancreatic cancer via arterial infusion
The present study aimed to investigate the therapeutic efficacy and clinical value of recombinant human adenovirus-p53 (rAd-p53) perfusion via the pancreatic artery for the treatment of mid-late stage pancreatic cancer. rAd-p53 (2×10(12) virus particles) in 6 ml normal saline was pushed (intravenous...
Gorde:
| Argitaratua izan da: | Oncol Lett |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696714/ https://ncbi.nlm.nih.gov/pubmed/29181104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7058 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|